drugset / Trial / NCT01498549
Cognitive Effects of Atomoxetine in Humans: Genetic Moderators
RandomizedCrossoverDouble-blindTreatment
Summary
The overall goal of this study is to determine if atomoxetine treatment improves selective cognitive functions in abstinent cocaine users, compared to healthy controls. The study will also test if a functional variation of the NET promoter polymorphic region (NETpPR) moderates the cognitive effects of atomoxetine.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 40 mg | — |
| Comparator | Atomoxetine | Other / unclassified | 80 mg | — |